Press release
Laser BPH Devices Market Expected to Reach $765.4 Million by 2031
Laser BPH devices market was valued at $460.25 million in 2021, and is estimated to reach $765.4 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031. Prostate enlargement, commonly known as benign prostatic hyperplasia (BPH), is a noncancerous expansion of the prostate gland. Frequent urination, difficulty starting to urinate, a weak stream, the inability to urinate, or a loss of bladder control are examples of symptoms. Urinary tract infections, bladder stones, and ongoing renal issues are examples of complications. Laser devices such as holmium laser, thulium laser, green light laser, and others such as diode laser, Nd:YAG laser, KTP/Nd: YAG laser are used to treat benign prostatic hyperplasia.๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Boston Scientific Corporation, Teleflex Incorporated, Agiliti Health, Inc., HealthTronics, Inc., Richard Wolf GmbH, Biolitec AG, Coloplast, Endo Pharmaceuticals Inc., Metrum Cryoflex, OmniGuide
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/11574
Based on type, the market is segmented into holmium laser, thulium laser, green light laser, and others. The holmium laser segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to rise in number of product launch and products approvals for holmium laser and increase in number of companies who manufactures laser BPH devices.
Based on procedure, the market is bifurcated into photoselective vaporization of the Prostate (PVP) and holmium laser ablation of the prostate (HoLAP). The holmium laser ablation of the prostate (HoLAP) segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to increase in the prevalence of benign prostate hyperplasia and rise in number of geriatric populations.
Based on end user, the market is divided into hospitals, clinics, and others. The hospitals segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to rise in expenditure by government to develop healthcare infrastructure and increase in number of hospitals and clinics.
North America accounted for most of the global laser BPH devices market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rise in the number of product launch and product approval, increase in the number of laser BPH devices industry, and developed healthcare infrastructure. Asia-Pacific is anticipated to witness lucrative growth during the forecast period, owing to rise in expenditure by government organization to develop the healthcare sector and increase in awareness regarding benign prostate hyperplasia.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/11574
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Laser BPH Devices Market Expected to Reach $765.4 Million by 2031 here
News-ID: 3250106 • Views: โฆ
More Releases from Allied Market Research
Spearmint Oil Market Growth Expected to See Next Level at a CAGR of 7.7%% by 203 โฆ
Allied Market Research published a report, titled, "Spearmint Oil Market by Source (Natural, and Organic), Form (Absolute, Concentrates, and Blends), and Application (Therapeutics, Aromatherapy, Food and Beverages, Cosmetics, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the "spearmint oil market" was valued at $180.1 million in 2023, and is estimated to reach $377.5 million by 2033, growing at a CAGR of 7.7% from 2024 toโฆ
[Latest 2026] Dithiocarbamate Market Set for 5% CAGR Growth Over the Next Decade โฆ
Allied Market Research published a report, titled, "Dithiocarbamate Market By Carbon Content (Mancozeb, Zineb, Propineb, and Others), and Application (Fruits And Vegetables, Flowers, Crops, and Others): Global Opportunity Analysis And Industry Forecast, 2023-2032". According to the report, the dithiocarbamate market valued for $0.7 billion in 2022 and is estimated to reach $1.1 billion by 2032, exhibiting a CAGR of 5.0% from 2023 to 2032.
Download Sample Pages of Research Overview:โฆ
[Latest] Sugarcane Wax Market Expanding at a Healthy CAGR of 3.6% by 2031
Allied Market Research published a report, titled, "Sugarcane Wax Market by End-use Industry (Pharmaceutical, Food, Cosmetics, Paper, Textile & leather, and Others), And Region (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031"
According to the report, the sugarcane wax market valued for 34.5 billion in 2021 and is estimated to surpass 48.6 million by 2031, exhibiting a CAGR of 3.6% from 2022-2031. The reportโฆ
Cotton Yarn Market is Expected to Reach Nearly USD 140.1 Billion by 2032
Allied Market Research published a report, titled, "Cotton Yarn Market by Type (Carded Yarn, Combed Yarn, Others), by Application (Apparel, Home Textiles, Industrial Textile, Others) Global Opportunity Analysis and Industry Forecast, 2023-2032 ". According to the report, The cotton yarn market was valued at $91.4 billion in 2022 and is estimated to reach $140.1 billion by 2032, exhibiting a CAGR of 4.4% from 2023 to 2032.
Download Sample Pages ofโฆ
More Releases for BPH
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M โฆ
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.โฆ
BPH Surgical Treatment Market worth $17.19 billion in 2030
Browse 368 market data Tables and 59 Figures spread through 328 Pages and in-depth TOC on "BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) - Global Forecast to 2030
The global [https://www.marketsandmarkets.com/Market-Reports/benign-prostatic-hyperplasia-treatment-market-198000374.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=benignprostatichyperplasiasurgicaltreatmentmarket], valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion inโฆ
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M โฆ
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.โฆ
Benign Prostatic Hyperplasia (BPH) Treatment Market Size and Forecast
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- The global Benign Prostatic Hyperplasia (BPH) Treatment Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The benign prostatic hyperplasia (BPH) treatment market is experiencing significant growth due to the rising prevalence of BPH among the aging maleโฆ
How big is Benign Prostate Hyperplasia (BPH) Market?
Benign Prostate Hyperplasia (BPH) Market is forecasted to reach at a CAGR of 6% during the forecast period (2024-2031).
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Benign Prostate Hyperplasia (BPH) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the marketโฆ
Benign prostatic hyperplasia: BPH drugs versus Dr Allenโs Device
The Global Treatment Market of Benign prostatic hyperplasia (BPH) was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025.
Thermobalancing therapy with Dr Allenโs Device was patented by the United States Patent and Trademark Office. Over a decade, thousands of men with BPH used or are using this non-invasive and side-effects free Dr Allenโs Device.โฆ
